We contribute to establishing a robust and competitive Cancer Cell Therapy pipeline at Astellas.

  • Modality
  • Project Code
  • Mechanism
  • Discovery
  • Preclinical
  • Phase 1
  • Partner
Cell Therapy
Not disclosed
CD20 convertibleCAR-T
position
Not disclosed
Mesothelin HiT TCR-T
position
Not disclosed
convertibleCAR-NK
position

Accurate as of January 2021

Programs listed above include programs of other Astellas affiliates [and those partnered with third parties].

Please see our overall Astellas Immuno-Oncology pipeline.